验证一种新的基于风险分层系统的管理方法,用于对甲素耐药的金黄色葡萄球菌菌病:分析多中心前性研究的分析
Taeeun Kim1, Sang-Rok Lee2, Seong Yeon Park3
1Division of Infectious Diseases, Department of Medicine, Nowon Eulji University Hospital, Seoul, Republic of Korea.
概括
一个新的风险系统有助于预测甲素耐药黄金葡萄球菌细菌病 (MRSAB) 的转移性感染. 虽然对指导治疗有希望,但需要进一步改进,以减少高风险和不确定的分类.
科学领域:
- 传染性疾病 传染性疾病
- 临床微生物学 临床微生物学
- 流行病学 流行病学
背景情况:
- 区分复杂和无复杂的金黄色葡萄球菌菌病 (SAB) 对于治疗至关重要.
- 目前的方法在捕捉SAB的异质性和指导诊断方面存在局限性.
- 针对SAB转移性感染提出了一个新的风险分层系统.
研究的目的:
- 评估一种新的风险分层系统对于甲素耐药SAB (MRSAB) 患者转移性感染的适用性.
- 评估系统预测转移性并发症和指导诊断和管理策略的能力.
主要方法:
- 对一组住院MRSAB患者的3年多中心,前性队列的回顾性分析.
- 根据新系统,将患者分为低风险,不确定的风险和高风险组.
- 对不同风险组的管理和结果进行比较.
主要成果:
- 在380名MRSAB患者中,86.1%是高风险,7.6%是不确定的,6.3%是低风险.
- 转移性感染率为19.6% (高风险),6.9% (不确定的) 和0% (低风险) (P < 0.001).
- 转移性并发症的独立预测因素包括疑似内心炎,临床症状,高匹特细菌病评分和持续性细菌病.
结论:
- 新的风险分层系统显示了预测MRSAB.转移性并发症的潜力.
- 它可以指导MRSAB患者的诊断工作和管理策略.
- 降低"高风险"和"不确定的"分类需要进一步改进.
更多相关视频
相关概念视频
01:26Mitral Stenosis III: Medical Management
535
Mitral stenosis, a condition marked by the narrowing of the mitral valve, necessitates an integrated approach for effective management. This approach includes preventative measures, medical therapy, and surgical interventions to reduce symptoms and prevent complications.PreventionPrevention of mitral stenosis primarily focuses on reducing the incidence of bacterial infections, particularly streptococcal infections, which can lead to rheumatic fever and subsequent valvular damage. Timely...
535
01:28Acute Pyelonephritis II: Diagnostic Studies and Management
842
Introduction:For diagnosing acute pyelonephritis, a comprehensive patient history is collected to identify symptoms such as dysuria, frequent or urgent urination, flank pain, or costovertebral angle (CVA) tenderness that may suggest a kidney infection.Physical ExaminationDuring the physical examination, CVA tenderness is assessed. This involves gentle percussion over the costovertebral angle, where tenderness often indicates a kidney infection.Diagnostic TestsUrinalysis: Used to identify white...
842
01:29Staphylococcal Skin Infections
143
Staphylococcus aureus is a Gram-positive coccus that resides harmlessly on the skin and mucous membranes of healthy individuals. When the skin barrier is breached, it can shift from a commensal to an opportunistic pathogen. This transition is facilitated by surface adhesins, such as clumping factor B and S. aureus surface protein G (SasG), which bind to structural proteins, including loricrin and cytokeratin, in the damaged epidermis. Protein A, another key factor, binds the Fc region of...
143
01:25Mechanism of Antibiotic Resistance in MRSA
219
Antibiotic resistance in bacteria arises when microorganisms evolve the ability to withstand drugs designed to kill them or inhibit their growth, rendering once-effective treatments useless. This phenomenon, driven by genetic change and selection under antibiotic exposure, poses a profound threat to modern medicine. Mechanisms include drug-inactivating enzymes (e.g., β-lactamases), efflux pumps that eject antibiotics, mutations altering antibiotic targets, decreased drug uptake, and...
219
01:25Clinical Significance of Antibiotic Resistance
90
Methicillin-resistant Staphylococcus aureus (MRSA) presents a critical public health threat, arising from its capacity to resist β-lactam antibiotics due to acquisition of the mecA gene within the staphylococcal cassette chromosome mec (SCCmec). This gene encodes penicillin-binding protein 2a (PBP2a), which impairs binding efficacy of methicillin and other β-lactams. MRSA has evolved into distinct clonal lineages impacting humans and animals alike, reinforcing its significance within...
90